Sökresultat - Twelves, Chris
- Visas 1 - 20 av 41 resultat
- Gå till nästa sida
-
1
-
2
-
3
-
4
-
5
-
6
Primary and secondary care management of women with early breast cancer from affluent and deprived areas: retrospective review of hospital and general practice records av Macleod, Una, Ross, Sue, Twelves, Chris, George, W D, Gillis, Charles, Watt, Graham C M
Publicerad 2000Text -
7
-
8
Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam av Perkins, Everett J., Posada, Maria, Kellie Turner, P., Chappell, Jill, Ng, Wee Teck, Twelves, Chris
Publicerad 2017Text -
9
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma av Twelves, Chris, Sabel, Michael, Checketts, Daniel, Miller, Sharon, Tayo, Bola, Jove, Maria, Brazil, Lucy, Short, Susan C.
Publicerad 2021Text -
10
Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis av O’Shaughnessy, Joyce, Cortes, Javier, Twelves, Chris, Goldstein, Lori J., Alexis, Karenza, Xie, Ran, Barrios, Carlos, Ueno, Takayuki
Publicerad 2020Text -
11
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer av Twelves, Chris, Awada, Ahmad, Cortes, Javier, Yelle, Louise, Velikova, Galina, Olivo, Martin S., Song, James, Dutcus, Corina E., Kaufman, Peter A.
Publicerad 2016Text -
12
Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer av Muss, Hyman, Cortes, Javier, Vahdat, Linda T., Cardoso, Fatima, Twelves, Chris, Wanders, Jantien, Dutcus, Corina E., Yang, Jay, Seegobin, Seth, O’Shaughnessy, Joyce
Publicerad 2014Text -
13
Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracyclin... av Kaufman, Peter A., Awada, Ahmad, Twelves, Chris, Yelle, Louise, Perez, Edith A., Velikova, Galina, Olivo, Martin S., He, Yi, Dutcus, Corina E., Cortes, Javier
Publicerad 2015Text -
14
Effect of Adjuvant Capecitabine or Fluorouracil, with or without Oxaliplatin, on Survival Outcomes in Stage III Colon Cancer and the Effect of Oxaliplatin on Post-Relapse Survival:... av Schmoll, Hans-Joachim, Twelves, Chris, Sun, Weijing, O'Connell, Michael J, Cartwright, Thomas, McKenna, Edward, Saif, Muhammad, Lee, Steve, Yothers, Greg, Haller, Daniel
Publicerad 2014Text -
15
Systemic treatment of hormone receptor positive, human epidermal growth factor 2 negative metastatic breast cancer: retrospective analysis from Leeds Cancer Centre av Twelves, Chris, Cheeseman, Sue, Sopwith, Will, Thompson, Matthew, Riaz, Majid, Ahat-Donker, Necibe, Myland, Melissa, Lee, Adam, Przybysz, Raymond, Turner, Stuart, Hall, Geoff, Perren, Tim
Publicerad 2020Text -
16
Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro av Hawsawi, Yousef, Humphries, Matthew P., Wright, Alexander, Berwick, Angelene, Shires, Mike, Al-Kharobi, Hanaa, El-Gendy, Reem, Jove, Maria, Twelves, Chris, Speirs, Valerie, Beattie, James
Publicerad 2016Text -
17
CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial av Coleman, Rob, Brown, Janet, Rathbone, Emma, Flanagan, Louise, Reid, Amber, Kendall, Jessica, Howell, Sacha, Twelves, Chris, Palmieri, Carlo, Anand, Anjana, MacPherson, Iain, Brown, Sarah
Publicerad 2020Text -
18
A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine av Twelves, Chris, Anthoney, Alan, Savulsky, Claudio I., Guo, Matthew, Reyderman, Larisa, Cresti, Nicola, Semiglazov, Vladimir, Timcheva, Constanta, Zubairi, Ishtiaq, Morrison, Rosemary, Plummer, Ruth, Evans, T. R. Jeffry
Publicerad 2019Text -
19
Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial av Franzoi, Maria Alice, Procter, Marion, Twelves, Chris, Ponde, Noam, Eiger, Daniel, Emond, Orianne, Clark, Emma, Parlier, Damien, Guillaume, Sébastien, Reaby, Linda, de Azambuja, Evandro, Bines, Jose
Publicerad 2022Text -
20
ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases av Tripathy, Debu, Tolaney, Sara M, Seidman, Andrew D, Anders, Carey K, Ibrahim, Nuhad, Rugo, Hope S, Twelves, Chris, Dieras, Veronique, Müller, Volkmar, Tagliaferri, Mary, Hannah, Alison L, Cortés, Javier
Publicerad 2019Text